Review Article
JBCGenetics. 2020; 3(1): 14-21

Prevalence of neurometabolic diseases in Saudi Arabia

Authors: Mohammed Almuqbil.

View PDF HTML Fulltext DOI: 10.24911/JBCGenetics/183-1585310179

Abstract

Neurometabolic disorders are most often seen in newborns and infants and have come to be recognized as an important group of disorders. Understanding diagnostic and therapeutic developments in neurometabolic disorders requires a concrete understanding of the classical principles of inborn errors of metabolism in order to provide key constructs for a fundamental understanding of this interesting category of disorders. The Saudi Arabian population has a comparatively high incidence of neurometabolic disorders, primarily due to consanguinity (with a high inbreeding coefficient factor) and large family sizes. The most frequently occurring group of disorders are lysosomal storage diseases, followed by organic acidemias; intellectual disability and cerebral palsy are the most commonly presented neurological features among Saudi Arabian children. This review summarizes the reports and studies of neurometabolic disorders prevalent in Saudi Arabia. It presents an overview of the types of disorders, current screening and diagnostic strategies, and prevalence of disease conditions in Saudi Arabia.

Keywords:   Neurometabolism, neurogenetics, Saudi Arabia


Request permissions

If you wish to reuse any part or all of this article please contact the copyright holder, contact@jbcgenetics.com.

Copyright ©2020. All Rights Reserved.

Prevalence of neurometabolic diseases in Saudi Arabia


Authors
Mohammed Almuqbil
College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia
PubMed articlesGoogle scholar articles


Correspondence to:
. Mohammed Almuqbil, College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; muqbilm@ksau-hs.edu.sa

Publication history
Received 27 Mar 2020
Revised 03 May 2020
Accepted 15 May 2020
Published in print 27 May 2020

How to cite this article

Pubmed Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. JBCGenetics. 2020; 3(1): 14-21. doi:10.24911/JBCGenetics/183-1585310179


Web Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. https://www.jbcgenetics.com//?mno=95331 [Access: October 27, 2020]. doi:10.24911/JBCGenetics/183-1585310179


AMA (American Medical Association) Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. JBCGenetics. 2020; 3(1): 14-21. doi:10.24911/JBCGenetics/183-1585310179


Vancouver/ICMJE Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. JBCGenetics. (2020), [cited October 27, 2020]; 3(1): 14-21. doi:10.24911/JBCGenetics/183-1585310179


Harvard Style

Mohammed Almuqbil (2020) Prevalence of neurometabolic diseases in Saudi Arabia. JBCGenetics, 3 (1), 14-21. doi:10.24911/JBCGenetics/183-1585310179


Turabian Style

Mohammed Almuqbil. 2020. Prevalence of neurometabolic diseases in Saudi Arabia. Journal of Biochemical and Clinical Genetics, 3 (1), 14-21. doi:10.24911/JBCGenetics/183-1585310179


Chicago Style

Mohammed Almuqbil. "Prevalence of neurometabolic diseases in Saudi Arabia." Journal of Biochemical and Clinical Genetics 3 (2020), 14-21. doi:10.24911/JBCGenetics/183-1585310179


MLA (The Modern Language Association) Style

Mohammed Almuqbil. "Prevalence of neurometabolic diseases in Saudi Arabia." Journal of Biochemical and Clinical Genetics 3.1 (2020), 14-21. Print. doi:10.24911/JBCGenetics/183-1585310179


APA (American Psychological Association) Style

Mohammed Almuqbil (2020) Prevalence of neurometabolic diseases in Saudi Arabia. Journal of Biochemical and Clinical Genetics, 3 (1), 14-21. doi:10.24911/JBCGenetics/183-1585310179


Click the icon of the social media platform on which you would like to share this article.